Compare ProShares UltraPro Short QQQ ETF (SQQQ) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares UltraPro Short QQQ ETF vs Teladoc Health Inc — how do they compare? ProShares UltraPro Short QQQ ETF trades at $38.99, while Teladoc Health Inc trades at $6.09 (market cap $1.11B). The key difference: Teladoc Health Inc is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| SQQQ | TDOC | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $89.43 | $9.72 |
52-Week Low | $36.04 | $4.47 |
Market Cap | — | $1.11B |
Enterprise Value | — | $1.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SQQQ, a 3x leveraged inverse ETF tracking the Nasdaq-100, trades at $38.31, up 0.34% on the day. Technical indicators are bearish with moving averages signaling sell, while oscillators remain neutral. The ETF is designed for short-term hedging against tech declines but faces structural erosion from daily resets, as highlighted by Seeking Alpha on 2026-06-26. Recent news suggests tactical use amid AI-driven market volatility, but long-term holding risks severe losses.
Outlook: SQQQ offers tactical downside protection in bearish tech markets but is unsuitable for long-term investment due to leverage decay. Risks include rapid value erosion and high volatility, requiring precise timing. Opportunities exist for hedging QQQ exposure during corrections, but investors must monitor Nasdaq-100 trends closely to avoid capital depletion.
TDOC trades at $6.26, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $200.32 million in 2025, though revenue remains stable at $2.53 billion. Analyst consensus is a hold with a $8.88 price target, while recent news highlights leadership changes and ongoing legal investigations.
The outlook is cautious; while valuation ratios like P/S of 0.45 and EV/EBITDA of 6.5 appear attractive, persistent losses and negative ROE of -12.99% pose risks. Upside depends on profitability improvements under new CFO Michael Grasher, but investor sentiment is tempered by weak earnings and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
